<DOC>
	<DOC>NCT00940108</DOC>
	<brief_summary>The purpose of this study is to determine whether CSL425 is a safe and effective vaccine for eliciting an immune response to H1N1 influenza in healthy children.</brief_summary>
	<brief_title>A Clinical Trial of CSL's 2009 H1N1 Influenza Vaccine (CSL425) in Healthy Children</brief_title>
	<detailed_description />
	<mesh_term>Influenza, Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Male or female aged &gt;= 6 months to &lt; 9 years at the time of the first study vaccination. For children &lt; 3 years of age at the time of first vaccination, born at or after 36 weeks of gestation. Known hypersensitivity to a previous dose of influenza virus vaccine or allergy to eggs, chicken protein, thiomersal, neomycin, polymyxin, or any components of the Study Vaccine.</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>8 Years</maximum_age>
	<verification_date>October 2013</verification_date>
</DOC>